Abstract

Accumulating evidence suggests that molecular alterations of peripheral leucocytes are possible diagnostic markers of acute myocardial infarction (AMI). Changed lipid/glucose metabolism is a prominent feature of the pathogenesis of AMI. Silent mating type information regulation 2 homolog 1 (SIRT1) and peroxisome proliferator-activated receptor gamma coactivator factor-α (PGC-1α) regulate mitochondrial function and energy metabolism. Thus, the gene expression of SIRT1 and PGC-1α in peripheral leucocytes isolated from AMI patients and their association with dyslipidemia have been evaluated. Fifty-five male subjects were divided into 40 patients with AMI and 15 healthy control subjects. Peripheral blood samples were obtained on the first day of AMI. Lipid profile parameters were assessed spectrophotometrically. Relative SIRT1 and PGC-1α expression were measured by real-time PCR. Compared with the control group, SIRT1 and PGC-1α expression were significantly decreased in the AMI group. SIRT1 expression was significantly negatively correlated with the age of the participants. SIRT1 expression was significantly positively correlated with PGC-1α expression. Both SIRT1 and PGC-1α expression were negatively correlated with markers of dyslipidemia. In conclusion, SIRT1 and PGC-1α expression are reduced in the acute phase of AMI, which addresses their possible role as potential biomarkers for AMI.

Highlights

  • Ischemic heart disease (IHD) is a major cause of death and disability worldwide

  • Previous reports described the role of SIRT1/PGC-1α in protecting against myocardial ischemia in which activation of SIRT1 and/or PGC-1α was associated with smaller infarct size and better post-Acute myocardial infarction (AMI) outcome[11,12,13]

  • Total cholesterol (TC), triacylglycerol (TAG) and lowdensity lipoprotein-cholesterol (LDL-C) were significantly higher in the AMI group when compared with the control group

Read more

Summary

INTRODUCTION

Acute myocardial infarction (AMI) is responsible to the major percent of IHD deaths due to its accompanied fatal complications[1]. Peripheral leucocytes were found to exhibit an alteration in their gene expression profile in patients with AMI4. PGC-1α upregulates the expression of several genes of the tricarboxylic acid cycle and mitochondrial FA oxidation pathway[9]. The SIRT1/PGC-1α pathway plays a role in regulating the activity of antioxidant enzymes[10]. Previous reports described the role of SIRT1/PGC-1α in protecting against myocardial ischemia in which activation of SIRT1 and/or PGC-1α was associated with smaller infarct size and better post-AMI outcome[11,12,13]. This study was conducted to address the possible diagnostic role of SIRT-1 and PGC-1α expression in peripheral leucocytes isolated from AMI patients and the association between these markers and the dyslipidemic profile observed in AMI patients

Subjects
Sample preparation
Lipid profile analysis
RNA isolation and real-time quantitative PCR
Statistical Analysis
Clinical characteristics
PGC-1α expression
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call